NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,710,000 | -8.8% | 83,843 | +0.3% | 0.00% | 0.0% |
Q2 2023 | $4,068,000 | -22.6% | 83,598 | -11.7% | 0.00% | 0.0% |
Q1 2023 | $5,254,000 | -19.7% | 94,623 | -41.9% | 0.00% | -50.0% |
Q4 2022 | $6,544,000 | +76.9% | 162,909 | +92.9% | 0.00% | +100.0% |
Q3 2022 | $3,700,000 | +49.7% | 84,440 | +21.1% | 0.00% | 0.0% |
Q2 2022 | $2,471,000 | +8.7% | 69,716 | +24.7% | 0.00% | 0.0% |
Q1 2022 | $2,274,000 | -85.0% | 55,905 | -65.6% | 0.00% | -66.7% |
Q4 2021 | $15,191,000 | +126.3% | 162,673 | +170.0% | 0.00% | +50.0% |
Q3 2021 | $6,713,000 | +31.9% | 60,239 | +34.4% | 0.00% | +100.0% |
Q2 2021 | $5,088,000 | +2.2% | 44,817 | -8.6% | 0.00% | 0.0% |
Q1 2021 | $4,977,000 | -16.4% | 49,013 | -18.0% | 0.00% | -50.0% |
Q4 2020 | $5,951,000 | +69.9% | 59,799 | +23.3% | 0.00% | +100.0% |
Q3 2020 | $3,502,000 | +89.8% | 48,481 | +31.0% | 0.00% | 0.0% |
Q2 2020 | $1,845,000 | +45.3% | 37,008 | -12.9% | 0.00% | 0.0% |
Q1 2020 | $1,270,000 | -20.9% | 42,509 | -10.8% | 0.00% | 0.0% |
Q4 2019 | $1,606,000 | +9.7% | 47,676 | +6.8% | 0.00% | 0.0% |
Q3 2019 | $1,464,000 | +14.0% | 44,626 | -4.1% | 0.00% | 0.0% |
Q2 2019 | $1,284,000 | +1505.0% | 46,518 | +1097.7% | 0.00% | – |
Q1 2019 | $80,000 | +185.7% | 3,884 | +93.6% | 0.00% | – |
Q4 2018 | $28,000 | -44.0% | 2,006 | -3.2% | 0.00% | – |
Q3 2018 | $50,000 | +19.0% | 2,073 | -7.0% | 0.00% | – |
Q2 2018 | $42,000 | +366.7% | 2,229 | +122.9% | 0.00% | – |
Q1 2018 | $9,000 | -18.2% | 1,000 | -21.1% | 0.00% | – |
Q4 2017 | $11,000 | -76.6% | 1,267 | -65.5% | 0.00% | – |
Q3 2017 | $47,000 | -6.0% | 3,672 | -19.8% | 0.00% | – |
Q2 2017 | $50,000 | +177.8% | 4,576 | +118.6% | 0.00% | – |
Q1 2017 | $18,000 | -40.0% | 2,093 | -20.1% | 0.00% | – |
Q4 2016 | $30,000 | +328.6% | 2,621 | +352.7% | 0.00% | – |
Q3 2016 | $7,000 | -30.0% | 579 | -27.6% | 0.00% | – |
Q2 2016 | $10,000 | +25.0% | 800 | 0.0% | 0.00% | – |
Q1 2016 | $8,000 | -20.0% | 800 | -9.4% | 0.00% | – |
Q4 2015 | $10,000 | +42.9% | 883 | +26.1% | 0.00% | – |
Q3 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |